Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
October 25, 2007 updated by: Korea Otsuka Pharmaceutical Co., Ltd.
to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients
Study Overview
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Recruiting
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy
Exclusion Criteria:
- Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
- Patients with performance status of ECOG score is more than 3
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
incidence and severity of oral mucositis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Do-Youn Oh, PhD, Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Study Completion (Anticipated)
March 1, 2008
Study Registration Dates
First Submitted
October 25, 2007
First Submitted That Met QC Criteria
October 25, 2007
First Posted (Estimate)
October 26, 2007
Study Record Updates
Last Update Posted (Estimate)
October 26, 2007
Last Update Submitted That Met QC Criteria
October 25, 2007
Last Verified
October 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 256-KOB-0701
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.